Sunday 21 January 2018 ShareProphets: The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

Cloudtag - 11 days from AIM death the zombie has news..well not really

By Tom Winnifrith, The Sheriff of AIM | Thursday 16 March 2017

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

In 11 days time if no Nomad is prepared to act for the fraud Cloudtag (CTAG), that is to say to sign off on the lies it likes to tell investors, its shares - now suspended - will be booted off AIM. Unable to raise cash it will go bust. Just to placate the fools who ignored countless warnings and are trapped in this stock and to amuse the rest of us it has today made an announcement. It is horeshite natch and I offer a translation service in bold.

Cloudtag, the Company that brings personal monitoring to the wellbeing, fitness and digital health markets wishes to reassure its shareholders that the Company and its directors remain fully committed to resolving the outstanding issues regarding its suspension from trading on AIM as soon as possible, and will provide an update to shareholders through the Regulatory Information Service (RIS) when appropriate.

We don't actually bring anything to the wellbeing, fitness and digital health markets just prototypes that do not actually work but we will pretend that we do.  The directors are trying to persuade a Nomad which is so utterly desperate for cash and has no reputation to lose to act on its behalf. The directors are committed to this. Any Nomad which signs up should be committed.

Additionally, the Company wishes to assure shareholders that all staff are focussed on delivering Cloudtag's first product, the Onitor Track, and the wider Company strategy of the digital health platform. As these matters progress, further updates will be made to shareholders in due course.

I know we have told folks that we would have guaranteed sales in the bag for more than a year now, that we would be shipping product and that big orders were there.l That was all a lie. We still have no product ready to ship, sale or even show in a working fashion at a trade fair. But how do you keep an idiot in suspense? We will tell our shareholders later.

In the meantime, the Company's directors request that all enquiries relating to the Company's current situation are directed to [email protected], where the team will endeavour to respond as soon as they can. Please do be aware that they will not be able to provide any further information than that currently in the public domain.

As our PR firm quit before Christmas and, since not even the low life morally bankrupt scumbags at Yellow Jersey will act for us, now we are doing IR in-house. Since the shares are not traded there is no point us leaking ( untrue) titbits to BB Morons so they can ramp the stock. And since nearly everything we leaked in the past was a lie this is just a charade to pretend we care.

Lastly, we would like to thank all shareholders for their continued support and patience as we work through this difficult period.

Shareholders have no choice as they are now locked in. The money has nearly all gone which is why there is no balance sheet update today and still no results to announce. We are a complete joke. Amit Ben Haim has got no cojones and wont face up and debate a lowly failed fund manager/pizza boy on April 1. But thanks for buying your shares, Andrew Regan is really glad he found real suckers to dump his stock onto at such crazy prices.

Laters Morons!

Filed under:

Never miss a story.

This area of the site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.

More on CTAG


Comments are turned off for this article.

Site by Everywhen